Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 11 | 2014 | 89 | 0.680 |
Why?
|
| Hospitals | 8 | 2014 | 71 | 0.650 |
Why?
|
| Quality Assurance, Health Care | 4 | 2012 | 62 | 0.520 |
Why?
|
| Medicare | 9 | 2012 | 119 | 0.450 |
Why?
|
| Community-Acquired Infections | 3 | 2008 | 29 | 0.430 |
Why?
|
| Surgical Wound Infection | 2 | 2011 | 104 | 0.420 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 87 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 5 | 2008 | 497 | 0.370 |
Why?
|
| Pneumonia, Bacterial | 1 | 2008 | 18 | 0.310 |
Why?
|
| Bacterial Infections | 1 | 2008 | 54 | 0.300 |
Why?
|
| Quality of Health Care | 3 | 2014 | 78 | 0.280 |
Why?
|
| United States | 15 | 2025 | 2060 | 0.250 |
Why?
|
| Limb Salvage | 1 | 2025 | 21 | 0.240 |
Why?
|
| Health Services, Indigenous | 1 | 2025 | 16 | 0.240 |
Why?
|
| Primary Health Care | 1 | 2025 | 151 | 0.210 |
Why?
|
| Hospitalization | 4 | 2014 | 189 | 0.210 |
Why?
|
| Peripheral Arterial Disease | 1 | 2025 | 119 | 0.200 |
Why?
|
| Diabetes Mellitus | 1 | 2025 | 213 | 0.200 |
Why?
|
| Myocardial Infarction | 4 | 2014 | 342 | 0.200 |
Why?
|
| Aged, 80 and over | 11 | 2014 | 1940 | 0.200 |
Why?
|
| Aged | 15 | 2014 | 5222 | 0.190 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2011 | 52 | 0.180 |
Why?
|
| Guideline Adherence | 4 | 2012 | 91 | 0.180 |
Why?
|
| Retrospective Studies | 10 | 2014 | 2454 | 0.170 |
Why?
|
| Humans | 29 | 2025 | 27119 | 0.150 |
Why?
|
| Utilization Review | 1 | 1998 | 9 | 0.150 |
Why?
|
| Patient Readmission | 2 | 2012 | 103 | 0.150 |
Why?
|
| Vaccination | 3 | 2003 | 175 | 0.140 |
Why?
|
| Male | 17 | 2014 | 13022 | 0.130 |
Why?
|
| Female | 21 | 2014 | 14635 | 0.130 |
Why?
|
| Hospital Mortality | 3 | 2012 | 146 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2025 | 2283 | 0.110 |
Why?
|
| Influenza, Human | 3 | 2003 | 84 | 0.100 |
Why?
|
| Pneumococcal Infections | 2 | 2002 | 23 | 0.100 |
Why?
|
| Time and Motion Studies | 1 | 2011 | 7 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2012 | 97 | 0.100 |
Why?
|
| Fungemia | 1 | 2011 | 5 | 0.100 |
Why?
|
| Transportation of Patients | 1 | 2011 | 28 | 0.100 |
Why?
|
| Candida | 1 | 2011 | 19 | 0.090 |
Why?
|
| Candidiasis | 1 | 2011 | 20 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 4 | 2014 | 49 | 0.090 |
Why?
|
| Cross Infection | 1 | 2011 | 35 | 0.090 |
Why?
|
| HIV Infections | 5 | 1994 | 149 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 68 | 0.090 |
Why?
|
| Time Factors | 6 | 2012 | 1570 | 0.090 |
Why?
|
| Risk | 1 | 2010 | 133 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 37 | 0.090 |
Why?
|
| HIV-1 | 4 | 1994 | 54 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2025 | 595 | 0.080 |
Why?
|
| Fluoroquinolones | 1 | 2008 | 15 | 0.080 |
Why?
|
| Cephalosporins | 1 | 2008 | 18 | 0.080 |
Why?
|
| Macrolides | 1 | 2008 | 19 | 0.080 |
Why?
|
| Nursing Homes | 1 | 2008 | 43 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 204 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 77 | 0.070 |
Why?
|
| Risk Factors | 4 | 2025 | 2030 | 0.070 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 160 | 0.070 |
Why?
|
| Influenza Vaccines | 2 | 2006 | 48 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 1994 | 44 | 0.070 |
Why?
|
| HIV Seropositivity | 5 | 1994 | 11 | 0.070 |
Why?
|
| Cohort Studies | 6 | 2011 | 863 | 0.060 |
Why?
|
| Physicians | 1 | 2006 | 80 | 0.060 |
Why?
|
| Logistic Models | 3 | 2011 | 398 | 0.050 |
Why?
|
| Inpatients | 1 | 2002 | 56 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 3 | 2012 | 234 | 0.050 |
Why?
|
| Adult | 6 | 2014 | 7492 | 0.050 |
Why?
|
| Middle Aged | 6 | 2011 | 6900 | 0.050 |
Why?
|
| Heart Failure | 2 | 2014 | 234 | 0.050 |
Why?
|
| Oklahoma | 2 | 2001 | 978 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 6 | 1994 | 8 | 0.040 |
Why?
|
| Age Distribution | 1 | 1998 | 70 | 0.040 |
Why?
|
| Sex Distribution | 1 | 1998 | 76 | 0.040 |
Why?
|
| Population Surveillance | 1 | 1998 | 85 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2011 | 67 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1994 | 22 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2011 | 705 | 0.030 |
Why?
|
| Adolescent | 3 | 2011 | 2988 | 0.030 |
Why?
|
| Hydrocarbons | 1 | 1996 | 41 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 1996 | 59 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 47 | 0.030 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2014 | 2 | 0.030 |
Why?
|
| Young Adult | 2 | 2011 | 2626 | 0.030 |
Why?
|
| African Americans | 2 | 2009 | 350 | 0.030 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 1993 | 1 | 0.030 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1993 | 2 | 0.030 |
Why?
|
| BCG Vaccine | 1 | 1993 | 13 | 0.030 |
Why?
|
| Diarrhea, Infantile | 1 | 1992 | 6 | 0.030 |
Why?
|
| Health Services Research | 1 | 2012 | 40 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2012 | 46 | 0.030 |
Why?
|
| Insurance Claim Reporting | 1 | 2011 | 3 | 0.020 |
Why?
|
| Malaria | 1 | 1991 | 15 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 1991 | 16 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 145 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 411 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 763 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 10 | 0.020 |
Why?
|
| Registries | 1 | 2011 | 383 | 0.020 |
Why?
|
| Prospective Studies | 4 | 1994 | 1219 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 928 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2003 | 278 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2008 | 8 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 1994 | 846 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2008 | 28 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 422 | 0.020 |
Why?
|
| Patient Selection | 1 | 2008 | 143 | 0.020 |
Why?
|
| Pregnancy | 4 | 1994 | 1149 | 0.020 |
Why?
|
| Medical Records | 1 | 2006 | 49 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2006 | 20 | 0.020 |
Why?
|
| Length of Stay | 1 | 2006 | 215 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 445 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2004 | 29 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 299 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2001 | 90 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 721 | 0.010 |
Why?
|
| Infant | 2 | 1992 | 966 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1996 | 25 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 264 | 0.010 |
Why?
|
| Life Tables | 1 | 1994 | 6 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1994 | 4 | 0.010 |
Why?
|
| Fathers | 1 | 1994 | 13 | 0.010 |
Why?
|
| Sexual Partners | 1 | 1994 | 24 | 0.010 |
Why?
|
| Family Health | 1 | 1994 | 71 | 0.010 |
Why?
|
| Parity | 1 | 1994 | 48 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1993 | 74 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1993 | 100 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1992 | 75 | 0.010 |
Why?
|
| Feces | 1 | 1992 | 107 | 0.010 |
Why?
|
| Mothers | 1 | 1993 | 112 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 930 | 0.010 |
Why?
|
| HIV Seroprevalence | 1 | 1990 | 1 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1990 | 19 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1990 | 209 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1991 | 404 | 0.010 |
Why?
|
| AIDS Serodiagnosis | 1 | 1989 | 1 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1989 | 16 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1989 | 15 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1990 | 508 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1989 | 129 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1989 | 279 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 10080 | 0.000 |
Why?
|